NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/08/2025
Back to search
Official data from USPTO
HERVOLUTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HERVOLUTION
ST13
US500000098393796Class
5, 35, 42
Filing
98393796
Registration
7854817
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 35, 42
Filing date
02/06/2024
Registration date
07/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/08/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Copenhagen, DK
Examiner
AVENT, TEAGUE A
Law office
N80
Current location
TMO LAW OFFICE 126
Holders and representatives
Holders
I. A. (pessoa física)
Representatives
Margaret C. McHugh Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary usenamely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancerimmune diseasesneurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseHuntington's diseaseamyotrophic lateral sclerosis (ALS)senescence associated diseases being age-related conditionsfrailtyosteoporosisliver steatosiscognitive decline; Viral-based immunotherapeutics being pharmaceutical preparationsin particular for the treatment of cancerimmune diseasesneurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseHuntington's diseaseALSsenescence associated diseases being age-related conditionsfrailtyosteoporosisliver steatosiscognitive decline
Class 35
Business managementorganization and administration; business management of licences for pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; retail store and wholescale store servicesonline retail store and wholesale store servicesin the field of pharmaceuticalsvaccines and medicinessuch as viral- based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases
Class 42
Research and development of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; medicalbiologicalscientific research relating to the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseasesin particular via immunotherapy
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2025
PUBO
PUBLISHED FOR OPPOSITION
05/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/14/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/14/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/22/2025
GNFR
FINAL REFUSAL E-MAILED
01/22/2025
CNFR
FINAL REFUSAL WRITTEN
01/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/30/2024
GNRT
NON-FINAL ACTION E-MAILED
08/30/2024
CNRT
NON-FINAL ACTION WRITTEN
08/30/2024
DOCK
ASSIGNED TO EXAMINER
08/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/04/2024
NWAP
NEW APPLICATION ENTERED
02/06/2024
Continuous trademark protection
Get notified about every new filing that threatens HERVOLUTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.